| Natural antioxidant compounds in risk factors for CVD. | |
| | |
MedLine Citation:
|
PMID: 17572098 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The benefits of drug treating hypertension, hyperglycemia and hyperlipidemias in terms of reduction of CVD morbidity and mortality are well established. However, there is epidemiological evidence that consumption of certain foods results to a reduction in myocardial infarction markers. Given in many reviews is the impact of dietary antioxidants pertained to LDL oxidation and to vascular endothelial dysfunction. The potential of a diet rich in these compounds on the management of hypertension, hyperglycemia and hyperlipidemias is hereby criticized. Although their clinical use not always translates into clinical benefit, data are motivating. In the future, these agents may be very important complementary treatment options for subjects with high risk for CVD. |
| | |
Authors:
|
Andriana C Kaliora; George V Z Dedoussis |
Related Documents
:
|
176718 - Serum beta-lipoprotein subfractions in polyacrylamide gel electrophoresis associated wi... 9369038 - Aggressive lipid lowering treatment in coronary atherosclerosis. 22586218 - Coronary wave intensity during the valsalva manoeuvre in humans reflects altered intram... 20675108 - Atherogenic dyslipidemia in patients with established coronary artery disease. 3694768 - Evaluation of coronary revascularization for ischemic heart disease: in the consecutive... 20670758 - Gene dosage of the common variant 9p21 predicts severity of coronary artery disease. |
Publication Detail:
|
Type: Journal Article; Review Date: 2007-05-10 |
Journal Detail:
|
Title: Pharmacological research : the official journal of the Italian Pharmacological Society Volume: 56 ISSN: 1043-6618 ISO Abbreviation: Pharmacol. Res. Publication Date: 2007 Aug |
Date Detail:
|
Created Date: 2007-08-31 Completed Date: 2007-11-01 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8907422 Medline TA: Pharmacol Res Country: England |
Other Details:
|
Languages: eng Pagination: 99-109 Citation Subset: IM |
Affiliation:
|
Department of Science of Dietetics-Nutrition, Harokopio University of Athens, 70 El. Venizelou Ave., 17671 Athens, Greece. akaliora@hua.gr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antihypertensive Agents / pharmacology, therapeutic use* Antilipemic Agents / pharmacology, therapeutic use* Antioxidants / pharmacology, therapeutic use* Cardiovascular Diseases / etiology, metabolism, physiopathology, prevention & control* Endothelium, Vascular / drug effects, physiopathology Humans Hyperglycemia / complications, drug therapy*, metabolism, physiopathology Hyperlipidemias / complications, drug therapy*, metabolism, physiopathology Hypertension / complications, drug therapy*, metabolism, physiopathology Hypoglycemic Agents / pharmacology, therapeutic use* Oxidative Stress / drug effects Risk Factors Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Antihypertensive Agents; 0/Antilipemic Agents; 0/Antioxidants; 0/Hypoglycemic Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Evidence of lowest brain penetration of an antiemetic drug, metopimazine, compared to domperidone, m...
Next Document: Tramadol is more effective than morphine and amitriptyline against ischaemic pain but not thermal pa...